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Abstract  24 
Purpose:  We investigated if the detrusor contraction during rapid bladder filling is 25 
provoked by cold or warm water. 26 
Patients & Methods: Patients suffering from neurogenic lower urinary tract 27 
dysfunction (NLUTD) were included into this randomized controlled double-blind trial. 28 
At the end of standard urodynamic investigation, the patients received 2 fillings of the 29 
bladder using a 4°C (ice water test, IWT) or 36°C ( warm water test, WWT) saline 30 
solution with a speed of 100 mL/min. The order was randomly selected and patients 31 
and investigators were blinded for the order sequence. Primary outcome measure 32 
was the occurrence of detrusor overactivity, maximum detrusor pressure and 33 
maximum bladder filling volume during IWT and WWT. 34 
Results: 40 patients (9 women, 31 men) where used for data analysis. NLUTD was 35 
caused by spinal cord injury in 33 and by other neurological disorders in 7 patients. 36 
Detrusor overactivity occurred significantly (p=0.02) more often during the IWT 37 
(30/40, 75%) than during the WWT (25/40, 63%), irrespective of the order of the test. 38 
Comparing IWT versus WWT, the maximum detrusor pressure was significantly 39 
(p<0.001) higher and the maximum bladder filling volume significantly (p<0.001) 40 
lower during the IWT. The order of performing the test (IWT first versus WWT first) 41 
had no effect on the parameters. 42 
Conclusions: Our findings imply that the more frequent occurrence of detrusor 43 
overactivity, higher maximum detrusor pressure and lower bladder filling volume in 44 
the IWT compared to the WWT are caused by cold water, underlying the theory of a 45 
C-fiber mediated bladder cooling reflex in humans. 46 
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Introduction 47 
The ice water test (IWT) was first described 1957 by Bors and Blinn1 in patients with 48 
spinal cord injury (SCI) to differentiate between upper (positive IWT) and lower 49 
(negative IWT) motoneuron lesion. However, subsequent studies found that the IWT 50 
is not specific to lesions of the upper motoneuron since also non-neurological 51 
patients showed a positive IWT and not all patients with an upper motoneuron 52 
condition had a positive IWT.2, 3, 4 53 
Animal studies in cats showed that the IWT is a C-fiber mediated lower motoneuron 54 
segmental reflex and that these unmyelinated C-fibers are associated with cold 55 
receptors in the bladder.5, 6, 7 In healthy humans, the IWT is positive up to the age of 56 
about 4 years8, 9 and becomes negative thereafter since the bladder cooling reflex is 57 
centrally inhibited. This reflex, however, might be unmasked by neurological 58 
disorders such as cerebrovascular accident, multiple sclerosis, Parkinson’s disease, 59 
SCI, spina bifida and others.8 60 
Considering that C-fibers are involved in the pathogenesis of detrusor overactivity, 61 
the IWT is an important diagnostic tool, especially in patients with an underlying 62 
neurological disorder.2, 10 Although there are many studies on the IWT,2 it is unclear 63 
whether the detrusor contraction during rapid bladder filling is provoked by cold or 64 
warm water. We therefore designed this randomized controlled double-blind trial. 65 
 66 
 67 
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Patients and Methods 68 
Patients 69 
Potential trial participants were recruited between October 2012 and March 2013 70 
from patients undergoing neuro-urological assessment11 at the Spinal Cord Injury 71 
Center, Balgrist University Hospital, Zürich, Switzerland. Study inclusion criteria were 72 
patients with neurogenic lower urinary tract dysfunction (NLUTD) aged ≥18 years. 73 
Pregnant and breast feeding women, patients aged <18 years, patients with current 74 
urinary tract infection and those who underwent intradetrusor onabotulinumtoxinA 75 
injections within the year before evaluation were excluded. 76 
The study was approved by the local ethics committee and registered with 77 
ClinicalTrials.gov (NCT identifier: NCT01773213). All subjects provided written 78 
informed consent prior to study inclusion. 79 
 80 
Randomization and blinding 81 
Patients were randomly assigned to undergo rapid bladder filling after standard 82 
urodynamic investigation (UDI) either first with cold water (IWT) and second with 83 
warm (warm water test, WWT) water or first with warm and second with cold water. 84 
Allocation was done on an equal basis (1:1) using independent random numbers 85 
generated by an internet service (random.org). Fluid packing for IWT and WWT 86 
looked identical and both patients and investigator (MK, an experience consultant in 87 
neuro-urology) involved in data analysis were blinded not being able to conclude on 88 
the test sequence. Randomization, fluid preparation and UDI were performed by the 89 
same staff nurse not involved in data analysis. 90 
 91 
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UDI, IWT and WWT 92 
UDIs were done in accordance to good urodynamic practices recommended by the 93 
International Continence Society.12, 13 Patients were urodynamically investigated in a 94 
sitting position whenever possible. A multichannel urodynamic system (Sedia®, 95 
Givisiez, Switzerland) was applied for all measurements. Pelvic floor 96 
electromyographical data were recorded via two perineal surface electrodes. Filling 97 
sensations were documented when applicable. Standard UDI was performed using 98 
36°C saline with a filling speed of 20-30 mL/min. P atients underwent two fast filling 99 
cystometries (IWT and WWT) after standard UDI according to our previous study.14 100 
The IWT was conducted with 4°C and the WWT with 36° C saline with a filling speed 101 
of 100 mL/min upon the occurrence of a detrusor contraction or upon a maximum 102 
bladder filling volume of 500 mL. 103 
 104 
Outcome measures 105 
Primary outcome measures were the occurrence of detrusor overactivity (yes/no), 106 
maximum detrusor pressure (cmH2O) and maximum bladder filling volume (mL) 107 
during IWT and WWT. 108 
Secondary outcome measures were sensations (no sensation or sensation of cold, 109 
urgency and pain), urinary incontinence (yes/no) and maximum heart rate (beats per 110 
minute) during IWT and WWT. 111 
Tertiary outcome measures were occurrence of adverse events during the study 112 
period. 113 
 114 
 115 
 116 
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Statistical analyses 117 
To detect a difference of 10 cmH2O in maximum detrusor pressure comparing IWT 118 
and WWT with a two-tailed t-test for paired samples at a significance level of 5% 119 
(α=0.05) and a statistical power of 80% (β=0.2) assuming a standard deviation of 120 
difference in the response of matched pairs of 20 cmH2O, we would have to include 121 
34 patients. Expecting a drop out rate of 10%, we decided to recruit at least 38 122 
patients.  123 
The effect of the order of IWT and WWT on occurrence of detrusor overactivity, 124 
maximum detrusor pressure, maximum bladder filling volume and maximum heart 125 
rate was analyzed using an ANOVA for repeated measures with within factor 126 
“temperature” (cold versus warm) and between factor “order” (cold first versus warm 127 
first). For this analysis, maximum detrusor pressure was logarithmically transformed 128 
(log10 of maximum detrusor pressure in cmH2O plus 1).  129 
To compare secondary outcome measures between IWT versus WWT, to investigate 130 
an order effect, and to compare the occurrence of detrusor overactivity during the 131 
standard UDI and the WWT, the the McNemar and the Fisher’s exact test were used. 132 
Statistical analyses were performed applying IBM® SPSS® Statistics version 23 133 
(IBM® Armonk, USA). A two-sided p-value <0.05 was considered statistically 134 
significant. 135 
 136 
 137 
  138 
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Results 139 
A total of 50 patients were assessed for trial eligibility (figure 1). Of these, 41 gave 140 
informed consent and were eventually randomized to IWT first (n=25) or WWT first 141 
(n=16). One patient of the IWT first group had to be excluded due to a technical 142 
problem leaving a total of 40 patients for analysis. 143 
Of the 40 analyzed patients, mean age was 50 ± 16 years (range 22 to 83), 9 (23%) 144 
were women and the cause of NLUTD was SCI in 33 patients (83%), multiple 145 
sclerosis in 2 (5%) and other neurological disorders in 5 (spina bifida, cerebral palsy, 146 
tethered cord syndrome, chronic inflammatory demyelinating polyneuropathy, 147 
herniated disk).  148 
Detrusor overactivity occurred significantly (p=0.02) more often during the IWT 149 
(30/40, 75%) than during the WWT (25/40, 63%), irrespective of the order of the test. 150 
Comparing IWT versus WWT, there was a significantly (p<0.001, figure 2) higher 151 
mean maximum detrusor pressure and a significantly (p<0.001, figure 3) lower mean 152 
maximum bladder filling volume during IWT. The order of performing the test (IWT 153 
first versus WWT first) showed no significant differences in mean maximum detrusor 154 
pressure (p=0.16, figure 2) and mean maximum bladder filling volume (p=0.61, figure 155 
3). Moreover, no significant (p>0.05) differences were found regarding secondary 156 
outcome measures, when comparing IWT versus WWT and the order of the test. 157 
A significant (p=0.006) difference was found comparing the occurrence of detrusor 158 
overactivity during the standard UDI (35/40, 88%) versus during the WWT (25/40, 159 
63%). 160 
No study related adverse events were reported. 161 
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Discussion 162 
In the present randomized controlled double-blind trial, we found more frequent 163 
occurrence of detrusor overactivity, higher maximum detrusor pressure and lower 164 
bladder filling volume in the IWT compared to the WWT. This implies that our results 165 
are caused by cold water, which is in line with the findings of several other non-166 
randomized studies, underlying the theory of a C-fiber mediated bladder cooling 167 
reflex in humans.2, 10  168 
 169 
The IWT is positive upon the age of about four years and becomes negative 170 
thereafter, since by growth the inhibiting signals from the central nervous system 171 
increase and the C-fiber reflex is suppressed.9 In the case of a disorder of the central 172 
nervous systems (for instance alterations in neural control such as in patients with 173 
SCI), the C-fiber reflex can often not be suppressed and the IWT becomes positive 174 
again.9 C-fiber mechanosensitivity might also change in response to chemical or 175 
thermal stimuli.10, 15. Classically, the IWT is used to differentiate between upper 176 
(positive IWT) and lower (negative IWT) motoneuron lesion.1, 2, 3, 4 However, a 177 
positive IWT in a significant percentage of patients with other urological conditions 178 
might indicate emerging C-fiber function compared to that in normal individuals in 179 
whom C-fibers are dormant.2 180 
Hellstroem et al.16 detected different types of detrusor contraction after cold water 181 
instillation compared to standard UDI and therefore assumed that the cold receptors 182 
shown in animal experiments are also present in the human urinary bladder. In 183 
agreement with our findings in humans, Fall et al.6 showed in animal experiments 184 
that detrusor contractions started earlier in the IWT compared to bladder filling with 185 
warm water. Using stepwise nerve transections, they revealed that the bladder is 186 
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mediated by unmyelinated C-fibers originating from cold receptors in the bladder and 187 
the urethra.6 Moreover, the detrusor pressure in cats increased by reducing the 188 
temperature of the infused saline keeping the infusion speed unchanged.6 These 189 
results are in line with the report by Geirsson et al.8 and also our findings. 190 
In animals, the micturition reflex seems A-delta mechanoreceptor driven with a higher 191 
threshold volume compared to the C-fiber mediated bladder cooling reflex.17, 18, 19 192 
Cold water may decrease the threshold volume leading to a reflex discharge in 193 
bladder preganglionic neurons.17, 18, 19. In addition, the bladder cooling reflex can be 194 
activated without any background activity of A-delta-fiber mediated 195 
mechanoreceptors of the bladder wall.7 Mainly based on animal research, it is 196 
generally assumed that A-delta fibers are essential for the initiation of the micturition 197 
reflex and that C-fibers primarily respond to noxious chemical and mechanical 198 
stimuli.20 The main findings of our randomized controlled trials, i.e. more frequent 199 
occurrence of detrusor overactivity, higher maximum detrusor pressure and lower 200 
bladder filling volume in the IWT compared to the WWT, further support this 201 
hypothesis and imply that in humans with NLUTD C-fibers become activated and 202 
facilitate pathological reflexes triggered by noxious stimuli such as cold water.  203 
Another relevant issue with the IWT is that the methods how to perform this test vary 204 
widely between the different studies.2 We used the same criteria for the IWT as 205 
Geirsson et al.10 but with a maximum bladder infusion volume of 500 mL to prevent 206 
false negative results by stopping the IWT too early. Although the IWT is recognized 207 
as a possible diagnostic tool to discriminate between an upper and lower moto-208 
neuron lesion by the European Association of Urology (EAU) Guideline on Neuro-209 
Urology,21 there is no generally agreed algorithm how to use this test in daily clinical 210 
practice and also the widely used guidelines/recommendations of the American 211 
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Urological Association (AUA),22 the EAU,21 the International Consultation on 212 
Incontinence (ICI),23 and the International Continence Society (ICS)12, 24 are not very 213 
instructive. Thus, standardization of the IWT is mandatory to compare results, 214 
determine specificity and sensitivity and define normative values to establish clinically 215 
relevant nomograms. Based on the literature2, 14 and our own findings, we 216 
recommend to perform the IWT using 4°C saline with a filling speed of 100 mL/min 217 
upon the occurrence of a detrusor contraction, urinary leakage, autonomic 218 
dysreflexia, or pain or upon a maximum bladder filling volume of 500 mL. 219 
Although we compared to the best of our knowledge for the first time urodynamic 220 
parameters of the IWT and WWT randomly and in a double-blind manner, our study 221 
has limitations. It should be considered that our unit is part of a highly specialized 222 
university spinal cord injury center so that a selection bias by inclusion of more 223 
severe cases, mixed population and/or unbalanced gender distribution cannot be 224 
completely excluded. Moreover, most of our patients were men and suffered from 225 
SCI but the limited total number of included patients did not allow for sub-group 226 
analysis. In addition, although we did find a significant difference between standard 227 
UDI and the WWT regarding the occurrence of detrusor overactivity, no definitive 228 
conclusions can be drawn regarding a potential effect of the filling speed since we did 229 
not randomize slow versus fast filling. However, it should be considered that a slow 230 
bladder filling with cold water would cause interpretation difficulties due to the 231 
heating-up of the cold water during the slow filling phase.  232 
 233 
 234 
 235 
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 236 
Conclusions 237 
The findings of our randomized controlled double-blind trial imply that the more 238 
frequent occurrence of detrusor overactivity, higher maximum detrusor pressure and 239 
lower bladder filling volume in the IWT compared to the WWT are caused by cold 240 
water, underlying the theory of a C-fiber mediated bladder cooling reflex in humans. 241 
 242 
 243 
  244 
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Figure 1. CONSORT flow diagram 
Assessed for eligibility (n=50) 
Excluded (n=9) 
♦   Not meeting inclusion criteria (n=5) 
♦   Declined to participate (n=4) 
 
Analysed (n=24) 
Allocated to IWT first (n=25) 
♦ Received allocated test (n=24) 
♦ Did not receive allocated intervention (n=1) 
due to a technical problem 
Allocated to WWT first (n=16) 
♦ Received allocated test (n=16) 
♦ Did not receive allocated intervention (n=0) 
 
Analysed (n=16)  
Allocation 
Analysis 
Randomized (n=41) 
Enrollment 
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Figure 2. Detrusor pressure (cmH2O) during the ice and warm water test (IWT, WWT). The 
mean maximum detrusor pressure was significantly (p<0.001) higher in the IWT compared to the 
WWT (n=40). The order of performing the test (IWT first versus WWT first) showed no significant 
(p>0.05) differences in mean maximum detrusor pressure. – (green) IWT first, WWT second 
(n=24), – (blue) WWT first, IWT second (n=16). SD = standard deviation. 
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Figure 3. Bladder filling volume (mL) during the ice and warm water test (IWT, WWT). 
The mean maximum bladder filling volume was significantly (p<0.001) lower in the IWT 
compared to the WWT (n=40). The order of performing the test (IWT first versus WWT first) 
showed no significant (p=0.61) differences in mean maximum bladder filling volume. – 
(green) IWT first, WWT second (n=24), – (blue) WWT first, IWT second (n=16). SD = 
standard deviation. 
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CONSORT 2010 checklist  Page 1 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 3 
2b Specific objectives or hypotheses 3 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 4 - 6 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons - 
Participants 4a Eligibility criteria for participants 4 
4b Settings and locations where the data were collected 4 - 5 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
4 - 5 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
5 
6b Any changes to trial outcomes after the trial commenced, with reasons - 
Sample size 7a How sample size was determined 5 
7b When applicable, explanation of any interim analyses and stopping guidelines 6 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 4 
8b Type of randomisation; details of any restriction (such as blocking and block size) 4 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
4 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
4 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 5 
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assessing outcomes) and how 
11b If relevant, description of the similarity of interventions  
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 6 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 6 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
7 
13b For each group, losses and exclusions after randomisation, together with reasons 7 
Recruitment 14a Dates defining the periods of recruitment and follow-up 4 
14b Why the trial ended or was stopped 5 / 4 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group - 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
7 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
7 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended 7 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
7 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) 7 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 10 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings  
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence  
Other information  
Registration 23 Registration number and name of trial registry 4 
Protocol 24 Where the full trial protocol can be accessed, if available - 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 12 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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Key of Definition 
NLUTD = neurogenic lower urinary tract dysfunction  
IWT  = ice water test  
SCI  = spinal cord injury 
UDI  = urodynamic investigation 
WWT  = warm water test 
 
